Ligand Pharmaceuticals Incorporated (LGND) Competitors

$112.50

$1.95 (-1.7%)
Last update: 04:00 PM EST
Day's range
$112.15
Day's range
$113.72

Ligand Pharmaceuticals Incorporated Competitors

Symbol Share Price Market Cap P/E Ratio Employee Count
AKRO

Akero Therapeutics, Inc.

$55.62 $4.43 B -14.83 69
ASND

Ascendis Pharma A/S

$170.80 $10.30 B -25.73 1017
LYEL

Lyell Immunopharma, Inc.

$9.74 $143.79 M -0.39 300
ETNB

89bio, Inc.

$10.41 $1.52 B -3.01 93
CGEM

Cullinan Oncology, Inc.

$8.61 $507.53 M -3.1 111
GPCR

Structure Therapeutics Inc.

$21.68 $1.25 B -8.69 163
ANNX

Annexon, Inc.

$2.49 $273.74 M -2.13 106
CYTK

Cytokinetics, Incorporated

$34.38 $4.11 B -6.5 498
ICVX

Icosavax, Inc.

$0.00 $769.04 M -6.96 60
VRDN

Viridian Therapeutics, Inc.

$15.88 $1.30 B -4.37 143
PASG

Passage Bio, Inc.

$0.39 $24.30 M -0.38 60
BPMC

Blueprint Medicines Corporation

$127.96 $8.26 B -50.98 682
CRNX

Crinetics Pharmaceuticals, Inc.

$31.77 $2.98 B -8.37 437
RLAY

Relay Therapeutics, Inc.

$3.22 $553.77 M -1.47 259
BGNE

BeiGene, Ltd.

$269.63 $20.21 B -22.55 10600
TERN

Terns Pharmaceuticals, Inc.

$3.88 $339.31 M -3.6 59
DSGN

Design Therapeutics, Inc.

$3.84 $218.56 M -3.89 56
ORIC

ORIC Pharmaceuticals, Inc.

$9.63 $683.87 M -5.12 122
APLS

Apellis Pharmaceuticals, Inc.

$18.83 $2.37 B -10.46 705
RCUS

Arcus Biosciences, Inc.

$9.25 $978.38 M -2.15 627